Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
584 of 1793




Newsletter Sign Up



Daily Readings

Gospel, John 11:19-27
and many Jews had come to Martha and Mary to comfort them about ... Read More

Saint of the Day

July 29 Saint of the Day

St. Martha
July 29: "Jesus loved Martha and Mary and Lazarus." This unique ... Read More